Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|August 12, 2022
Special Issue "Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: Diagnosis and Treatment"Lorenzo Lorusso, Giovanni Ricevuti
Immunity & Ageing : I & A|September 19, 2012
Alzheimer disease and platelets: how's that relevantSilvia Catricala, Mauro Torti, Giovanni Ricevuti
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Linking atherosclerosis to Alzheimer's disease: focus on biomarkersEnzo Emanuele, Valentina Martinelli, Vera Abbiati, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 23, 2025
Intravenous glutathione should not be mismatched with ozone as an antioxidant therapySalvatore Chirumbolo, Marianno Franzini, Giovanni Ricevuti, et al.
Chemical Biology & Drug Design|August 9, 2007
The antimicrobial peptide PR-39 has a protective effect against HeLa cell apoptosisChristopher R Ross, Giovanni Ricevuti, Anna Ivana Scovassi
Journal of Clinical Medicine|November 13, 2021
The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic ApplicationsAngelica Varesi, Undine-Sophie Deumer, Sanjana Ananth, et al.
International Reviews of Immunology|August 22, 2002
Immune activation as effect modifier of atherogenesis in chronic infectionGiovanni Ricevuti, Donatella Gritti, Chiara Gasparetto, et al.
Clinical Interventions in Aging|January 8, 2015
Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patientsFabio Guerriero, Carmelo Sgarlata, Claudio Marcassa, et al.
Ageing Research Reviews|August 19, 2020
Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disordersCatia Scassellati, Antonio Carlo Galoforo, Cristian Bonvicini, et al.
Pageof 9